This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Mild Cognitive Impairment or Alzheimer's Disease
and you are
between 55 and 90
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

Cognitively normal individuals, patients with Mild Cognitive Impairment (MCI) or Alzheimer's Disease (AD) will undergo clinical screening, neuropsychological tests, blood and urine analyses, quantitative magnetic resonance imaging (MRI) and proton (1H ) and carbon 13 (13C) magnetic resonance spectroscopy (MRS). Each individual will receive minocycline oral administration for 4 weeks initially, after which MRI, MRS and neuropsychological results will be recorded. If no adverse side effects occur, subjects will continue minocycline administration for an additional 5 months.

Provided treatments

  • Drug: Minocycline

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01463384. The sponsor of the trial is Huntington Medical Research Institutes and it is looking for 13 volunteers for the current phase.
Official trial title:
MRI and MRS Diagnosis and Treatment Monitoring of Alzheimer's Disease With Novel Therapy